VCL-6365 (Vical)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameVCL-6365 (Vical)

Drug Alias NameVaxfectin formulated cytomegalovirus prophylactic DNA vaccineCytomegalovirus DNA vaccine monovalentCytomegalovirus prophylactic vaccinegB CMV vaccineVaxfectin +[8]

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCytomegalovirus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesFresh Tracks Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesVirginia Commonwealth University

Active IndicationsN/A

Inactive IndicationsCytomegalovirus Infections

Other Information

ATC CodeN/A